Alzheimer; News from the web:

Unfortunately not. Here the sad story about another two drugs that have failed in the trials.

Both bapineuzumab and solanezumab did not improve patients’ ability to think and solve problems, according to findings published in the Jan. 23 issue of the New England Journal of Medicine.

Read all about it HERE